Engineering the microcirculation.
暂无分享,去创建一个
[1] Lucie Germain,et al. In vitro reconstruction of a human capillary‐like network in a tissue‐engineered skin equivalent , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[2] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.
[3] Hiroshi Takahashi,et al. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon , 1999, Nature Medicine.
[4] N. Ferrara,et al. Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.
[5] J. Pearlman,et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. , 1999, Circulation.
[6] Wayne A Morrison,et al. An arteriovenous loop in a protected space generates a permanent, highly vascular, tissue‐engineered construct , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] R. Lederman,et al. Testing clinical therapeutic angiogenesis using basic fibroblast growth factor (FGF‐2) , 2003, British journal of pharmacology.
[8] D J Mooney,et al. Release from alginate enhances the biological activity of vascular endothelial growth factor. , 1998, Journal of biomaterials science. Polymer edition.
[9] Y. Suárez,et al. Vascularization and engraftment of a human skin substitute using circulating progenitor cell‐derived endothelial cells , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Chad Johnson,et al. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. , 2004, Biomaterials.
[11] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[12] R. Ross,et al. Effects of growth factors in vivo. I. Cell ingrowth into porous subcutaneous chambers. , 1987, The American journal of pathology.
[13] S. Weiss,et al. Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.
[14] P. D’Amore,et al. Capillary growth: a two-cell system. , 1992, Seminars in cancer biology.
[15] A. Khorana,et al. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. , 2006, Blood.
[16] F. Cui,et al. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin , 2005, Journal of Neuroscience Methods.
[17] J. Tien,et al. Computational design of drainage systems for vascularized scaffolds. , 2009, Biomaterials.
[18] W A Morrison,et al. Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. , 2002, British journal of plastic surgery.
[19] Axel R. Pries,et al. Remodeling of Blood Vessels: Responses of Diameter and Wall Thickness to Hemodynamic and Metabolic Stimuli , 2005, Hypertension.
[20] J. Winer,et al. The vascular endothelial growth factor family of polypeptides , 1991, Journal of cellular biochemistry.
[21] C. Hunt,et al. Observations of the microcirculatory bed in rat mesocecum using differential interference constrast microscopy in vivo and electron microscopy. , 1976, The American journal of anatomy.
[22] J. Kim,et al. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. , 2000, Circulation research.
[23] G. Wnek,et al. Encyclopedia of biomaterials and biomedical engineering , 2008 .
[24] H. Dvorak,et al. Angiogenesis Therapy: Amidst the Hype, the Neglected Potential for Serious Side Effects , 2001, Circulation.
[25] J. Fiddes,et al. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.
[26] G. Lip,et al. Angiogenesis: basic pathophysiology and implications for disease. , 2003, European heart journal.
[27] Y. Ikada,et al. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. , 2000, Biomaterials.
[28] J. Kelly,et al. Generation of a vascularized organoid using skeletal muscle as the inductive source , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] Pieter Koolwijk,et al. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells , 2004, Angiogenesis.
[30] Thomas N. Sato,et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.
[31] J. Ware,et al. Angiogenesis in ischemic heart disease , 1997, Nature Medicine.
[32] D. Ingber,et al. Mechanotransduction: All Signals Point to Cytoskeleton, Matrix, and Integrins , 2002, Science's STKE.
[33] L. McIntire. Vascular Assembly in Engineered and Natural Tissues , 2002, Annals of the New York Academy of Sciences.
[34] K. Dutt,et al. Three-dimensional model of angiogenesis: coculture of human retinal cells with bovine aortic endothelial cells in the NASA bioreactor. , 2003, Tissue engineering.
[35] Haruchika Masuda,et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization , 1999, Nature Medicine.
[36] M. Lampugnani,et al. Fibrinogen induces endothelial cell adhesion and spreading via the release of endogenous matrix proteins and the recruitment of more than one integrin receptor. , 1990, Blood.
[37] M. Gerritsen,et al. Lumen Formation In Vivo Versus In Vitro Observations , 2003, Microcirculation.
[38] Federica Boschetti,et al. Synergy between interstitial flow and VEGF directs capillary morphogenesis in vitro through a gradient amplification mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] T. Coenye,et al. An epidemic Burkholderia cepacia complex strain identified in soil , 2002, The Lancet.
[40] J. Isner,et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. , 1998, Circulation.
[41] A. Perets,et al. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. , 2003, Journal of biomedical materials research. Part A.
[42] David J Mooney,et al. Engineering vascular networks in porous polymer matrices. , 2002, Journal of biomedical materials research.
[43] I. Yannas,et al. Antigenicity and immunogenicity of collagen. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.
[44] Judith M Curran,et al. The use of poly(l-lactide) and RGD modified microspheres as cell carriers in a flow intermittency bioreactor for tissue engineering cartilage. , 2006, Biomaterials.
[45] Geraldine Mitchell,et al. The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lactic-co-glycolic acid) scaffolds in vitro and in vivo. , 2006, Biomaterials.
[46] K J Gooch,et al. Biomaterial-microvasculature interactions. , 2000, Biomaterials.
[47] J. Quigley,et al. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.
[48] E. Nabel,et al. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo , 1993, Nature.
[49] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[50] S. Rafii,et al. Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1 , 2001, Annals of the New York Academy of Sciences.
[51] L Orci,et al. In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices , 1983, The Journal of cell biology.
[52] Robert Langer,et al. Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.
[53] R. Langer,et al. Tissue engineering: current state and perspectives , 2004, Applied Microbiology and Biotechnology.
[54] A. Smit,et al. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial. , 2006, Human Gene Therapy.
[55] J. Pober,et al. Cytoprotection of Human Umbilical Vein Endothelial Cells Against Apoptosis and CTL-Mediated Lysis Provided by Caspase-Resistant Bcl-2 Without Alterations in Growth or Activation Responses1 , 2000, The Journal of Immunology.
[56] C. Heeschen,et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. , 2003, Blood.
[57] Y. M. Elçin,et al. Controlled release of endothelial cell growth factor from chitosan-albumin microspheres for localized angiogenesis: in vitro and in vivo studies. , 1996, Artificial cells, blood substitutes, and immobilization biotechnology.
[58] P. Kristjansen,et al. Angiogenic synergy of bFGF and VEGF is antagonized by Angiopoietin-2 in a modified in vivo Matrigel assay. , 2004, Microvascular research.
[59] J. Rhodin,et al. The ultrastructure of mammalian arterioles and precapillary sphincters. , 1967, Journal of ultrastructure research.
[60] Linda G Griffith,et al. Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.
[61] P. Rogers,et al. Blood Vessel Growth in the Endometrium , 1995, Microcirculation.
[62] V. Backman,et al. A biodegradable vascularizing membrane: a feasibility study. , 2007, Acta biomaterialia.
[63] J M Anderson,et al. Inflammatory response to implants. , 1988, ASAIO transactions.
[64] Y. Tabata,et al. Bioartificial Pancreas Transplantation at Prevascularized Intermuscular Space: Effect of Angiogenesis Induction on Islet Survival , 2003, Pancreas.
[65] M. Shibata,et al. Effects of shear stress on wound-healing angiogenesis in the rabbit ear chamber. , 1997, The Journal of surgical research.
[66] D. Cheresh,et al. Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.
[67] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[68] Laura E. Niklason,et al. Replacement Arteries Made to Order , 1999, Science.
[69] Juan P. Albar,et al. Membrane Type 1-Matrix Metalloproteinase Is Activated during Migration of Human Endothelial Cells and Modulates Endothelial Motility and Matrix Remodeling* , 2001, The Journal of Biological Chemistry.
[70] Y. Ikada,et al. De novo formation of adipose tissue by controlled release of basic fibroblast growth factor. , 2000, Tissue engineering.
[71] A. Barger,et al. Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.
[72] B R Johansson,et al. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. , 1997, Science.
[73] Andrés J. García,et al. Inhibition of in vitro chondrogenesis in RGD-modified three-dimensional alginate gels. , 2007, Biomaterials.
[74] W A Morrison,et al. Formation of new tissue from an arteriovenous loop in the absence of added extracellular matrix. , 2000, Tissue engineering.
[75] A. E. Elçin,et al. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. , 2006, Tissue engineering.
[76] Anthony Atala,et al. Controlled fabrication of a biological vascular substitute. , 2006, Biomaterials.
[77] G Tellides,et al. In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[78] Julie H. Campbell,et al. Development of tissue engineered vascular grafts. , 2007, Current pharmaceutical biotechnology.
[79] Takayuki Asahara,et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb , 1996, The Lancet.
[80] Y. Tabata,et al. Maintenance of Neovascularization at the Implantation Site of an Artificial Device by bFGF and Endothelial Cell Transplant , 2006, Cell transplantation.
[81] C. Garlanda,et al. Heterogeneity of endothelial cells. Specific markers. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[82] L. Niklason. Techview: medical technology. Replacement arteries made to order. , 1999, Science.
[83] G. Stevens,et al. The Influence of Extracellular Matrix on the Generation of Vascularized, Engineered, Transplantable Tissue , 2001, Annals of the New York Academy of Sciences.
[84] R. Jain,et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo , 2007, Nature Biotechnology.
[85] Philippe Leboulch,et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2 , 2003, Nature Medicine.
[86] A. Quyyumi,et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris. , 2000, The American journal of cardiology.
[87] J. Isner,et al. Stromal Cell–Derived Factor-1 Effects on Ex Vivo Expanded Endothelial Progenitor Cell Recruitment for Ischemic Neovascularization , 2003, Circulation.
[88] W. Morrison,et al. Angiogenic growth factor synergism in a murine tissue engineering model of angiogenesis and adipogenesis. , 2007, The American journal of pathology.
[89] Y. M. Elçin,et al. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. , 2001, Artificial organs.
[90] A. Desmoulière,et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. , 1995, The American journal of pathology.
[91] W. Morrison,et al. Implanted myoblast survival is dependent on the degree of vascularization in a novel delayed implantation/prevascularization tissue engineering model. , 2010, Tissue engineering. Part A.
[92] R. C. Johnson,et al. Neovascularization of synthetic membranes directed by membrane microarchitecture. , 1995, Journal of biomedical materials research.
[93] H. Bøtker,et al. NOGA-Guided Analysis of Regional Myocardial Perfusion Abnormalities Treated With Intramyocardial Injections of Plasmid Encoding Vascular Endothelial Growth Factor A-165 in Patients With Chronic Myocardial Ischemia: Subanalysis of the EUROINJECT-ONE Multicenter Double-Blind Randomized Study , 2005, Circulation.
[94] Jeffrey R Capadona,et al. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports. , 2006, Biomaterials.
[95] R M Nerem,et al. Tissue engineering a blood vessel substitute: the role of biomechanics. , 2000, Yonsei medical journal.
[96] Peter Carmeliet,et al. Angiogenesis in life, disease and medicine , 2005, Nature.
[97] Z. Lokmic,et al. Vascularization of Engineered Constructs , 2008 .
[98] Y. Ouchi,et al. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B–PDGFRβ signaling , 2005, Journal of Cell Science.
[99] A. Quyyumi,et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. , 2000, Journal of the American College of Cardiology.
[100] B. Frerich,et al. In vitro model of a vascular stroma for the engineering of vascularized tissues. , 2001, International journal of oral and maxillofacial surgery.
[101] W M Reichert,et al. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. , 1998, Journal of biomedical materials research.
[102] U. Dirnagl,et al. Estrogen Increases Bone Marrow‐Derived Endothelial Progenitor Cell Production and Diminishes Neointima Formation , 2003, Circulation.
[103] W. Morrison,et al. Generation of an autologous tissue (matrix) flap by combining an arteriovenous shunt loop with artificial skin in rats: preliminary report. , 2000, British journal of plastic surgery.
[104] R. Lederman,et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial , 2002, The Lancet.
[105] M J Yaszemski,et al. Polymer concepts in tissue engineering. , 1998, Journal of biomedical materials research.
[106] Shulamit Levenberg,et al. Endothelial cells derived from human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[107] O. Volpert,et al. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.
[108] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[109] J. Kelly,et al. Contact with existing adipose tissue is inductive for adipogenesis in matrigel. , 2006, Tissue engineering.
[110] K. Ueda,et al. Tissue Engineering Skin Flaps: Which Vascular Carrier, Arteriovenous Shunt Loop or Arteriovenous Bundle, Has More Potential for Angiogenesis and Tissue Generation? , 2003, Plastic and reconstructive surgery.
[111] O O Erol,et al. New capillary bed formation with a surgically constructed arteriovenous fistula. , 1980, Plastic and reconstructive surgery.
[112] Dai Fukumura,et al. Tissue engineering: Creation of long-lasting blood vessels , 2004, Nature.
[113] Rui L Reis,et al. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. , 2010, Macromolecular bioscience.
[114] D. Shima,et al. The Mouse Gene for Vascular Endothelial Growth Factor , 1996, The Journal of Biological Chemistry.
[115] Till Acker,et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions , 2001, Nature Medicine.
[116] Aravinda Thiagalingam,et al. Organization of Myocardial Activation During Ventricular Fibrillation After Myocardial Infarction: Evidence for Sustained High-Frequency Sources , 2005, Circulation.
[117] Melody A Swartz,et al. Engineered blood and lymphatic capillaries in 3‐D VEGF‐fibrin‐collagen matrices with interstitial flow , 2007, Biotechnology and bioengineering.
[118] Julie H. Campbell,et al. Tissue-Engineered Blood Vessels: Alternative to Autologous Grafts? , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[119] Andrew J. Ewald,et al. Matrix metalloproteinases and the regulation of tissue remodelling , 2007, Nature Reviews Molecular Cell Biology.
[120] G. E. Gilbert,et al. Slowed Release of Thrombin-cleaved Factor VIII from von Willebrand Factor by a Monoclonal and a Human Antibody Is a Novel Mechanism for Factor VIII Inhibition* , 1996, The Journal of Biological Chemistry.
[121] D. Kohane,et al. Engineering vascularized skeletal muscle tissue , 2005, Nature Biotechnology.
[122] E. Raines,et al. Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. , 2000, Circulation research.
[123] J. Converse,et al. Inosculation of vessels of skin graft and host bed: a fortuitous encounter. , 1975, British journal of plastic surgery.
[124] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[125] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[126] D. Kaplan,et al. Biopolymer-based biomaterials as scaffolds for tissue engineering. , 2006, Advances in biochemical engineering/biotechnology.
[127] Silviu Itescu,et al. Cardiac Tissue Engineering in an In Vivo Vascularized Chamber , 2007, Circulation.
[128] E. Keshet,et al. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.
[129] Vladimir Mironov,et al. Organ printing: tissue spheroids as building blocks. , 2009, Biomaterials.
[130] Robert Langer,et al. Local delivery of basic fibroblast growth factor increases both angiogenesis and engraftment of hepatocytes in tissue-engineered polymer devices1 , 2002, Transplantation.
[131] Elisabetta Dejana,et al. Endothelial cell–cell junctions: happy together , 2004, Nature Reviews Molecular Cell Biology.
[132] W M Reichert,et al. Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. , 1998, Journal of biomedical materials research.
[133] N. Simionescu,et al. The Cardiovascular System , 1983 .
[134] D. Young,et al. Species-specific in situ hybridization with fluorochrome-labeled DNA probes to study vascularization of human skin grafts on athymic mice. , 1996, The Journal of burn care & rehabilitation.
[135] Susanne M. Smorenburg,et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. , 2000, Cancer research.
[136] M. Makuuchi,et al. G-CSF stimulates angiogenesis and promotes tumor growth: potential contribution of bone marrow-derived endothelial progenitor cells. , 2002, Biochemical and biophysical research communications.
[137] J. Ware,et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. , 2002, The Journal of thoracic and cardiovascular surgery.
[138] D. Vittet,et al. In Vitro Models of Vasculogenesis and Angiogenesis , 2001, Laboratory Investigation.
[139] J. Pober,et al. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[140] Hyun Jung Chung,et al. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. , 2006, Journal of biomedical materials research. Part A.
[141] Joan E Sanders,et al. Tissue engineering of perfused microvessels. , 2003, Microvascular research.
[142] R. Padera,et al. Time course of membrane microarchitecture-driven neovascularization. , 1996, Biomaterials.
[143] Judah Folkman,et al. Angiogenesis in vitro , 1980, Nature.
[144] J. Winer,et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. , 1991, Molecular endocrinology.
[145] J. Vacanti,et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. , 2000, Tissue engineering.
[146] J. Isner,et al. Endothelial Progenitor Cell Vascular Endothelial Growth Factor Gene Transfer for Vascular Regeneration , 2002, Circulation.
[147] Bruce K Milthorpe,et al. Engineering thick tissues--the vascularisation problem. , 2007, European cells & materials.
[148] D E Ingber,et al. Extracellular matrix controls tubulin monomer levels in hepatocytes by regulating protein turnover. , 1994, Molecular biology of the cell.
[149] H. Vandenburgh,et al. Recombinant Vascular Endothelial Growth Factor Secreted From Tissue-Engineered Bioartificial Muscles Promotes Localized Angiogenesis , 2001, Circulation.
[150] A. Atala,et al. In Vitro Systems for Tissue Engineering , 2002, Annals of the New York Academy of Sciences.
[151] Holger Gerhardt,et al. Endothelial-pericyte interactions in angiogenesis , 2003, Cell and Tissue Research.
[152] R. Lang,et al. Apoptosis during macrophage-dependent ocular tissue remodelling. , 1994, Development.
[153] V. Dixit,et al. Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[154] P. Koolwijk,et al. Role of Fibrin Matrix in Angiogenesis , 2001, Annals of the New York Academy of Sciences.
[155] D. McDonald,et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. , 2004, The American journal of pathology.
[156] M. Dake,et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.
[157] Holger Gerhardt,et al. How do endothelial cells orientate? , 2005, EXS.
[158] T. Skalak,et al. The FASEB Journal express article 10.1096/fj.03-0933fje. Published online February 6, 2004. Multicellular simulation predicts microvascular patterning and in silico tissue assembly , 2022 .
[159] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[160] Kyunghee Choi,et al. Evidence for the hemangioblast. , 2005, Experimental hematology.
[161] Wayne A Morrison,et al. Adipose tissue engineering based on the controlled release of fibroblast growth factor-2 in a collagen matrix. , 2006, Tissue engineering.
[162] O. Wendler,et al. Expression and function of laminins in the embryonic and mature vasculature. , 2005, Physiological reviews.
[163] A. Griffioen,et al. Molecular pathways of angiogenesis inhibition. , 2007, Biochemical and biophysical research communications.
[164] J. Stingl. Fine structure of precapillary arterioles of skeletal muscle in the rat. , 1976, Acta anatomica.
[165] A Krogh,et al. The number and distribution of capillaries in muscles with calculations of the oxygen pressure head necessary for supplying the tissue , 1919, The Journal of physiology.
[166] S. Mahooti,et al. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. , 1998, Journal of cell science.
[167] Melody A Swartz,et al. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. , 2004, Microvascular research.
[168] P. Sykes,et al. How soon may the axial vessels of a surviving free flap be safely ligated: a study in pigs. , 1978, British journal of plastic surgery.
[169] Jingsong Xu,et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo , 2001, The Journal of cell biology.
[170] Y. Tabata,et al. Recent progress in tissue engineering. , 2001, Drug discovery today.
[171] A. Hess,et al. The venous graft as an effector of early angiogenesis in a fibrin matrix. , 2008, Microvascular research.
[172] Brigitte Vollmar,et al. Inosculation: connecting the life-sustaining pipelines. , 2009, Tissue engineering. Part B, Reviews.
[173] N. Ferrara. The role of VEGF in the regulation of physiological and pathological angiogenesis. , 2005, EXS.
[174] P. D’Amore,et al. Cellular interactions in vascular growth and differentiation. , 2001, International review of cytology.
[175] K. Yasuda,et al. In situ regeneration of adipose tissue in rat fat pad by combining a collagen scaffold with gelatin microspheres containing basic fibroblast growth factor. , 2006, Tissue engineering.
[176] Hyun Jung Chung,et al. Heparin Immobilized Porous PLGA Microspheres for Angiogenic Growth Factor Delivery , 2006, Pharmaceutical Research.
[177] David J Mooney,et al. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[178] J. Hurley,et al. Prefabrication of thin transferable axial-pattern skin flaps: an experimental study in rabbits. , 1990, British journal of plastic surgery.
[179] M. Tanihara,et al. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. , 2001, Journal of biomedical materials research.
[180] M. Endres,et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. , 2003, Circulation.
[181] M C Davies,et al. Interactions of 3T3 fibroblasts and endothelial cells with defined pore features. , 2002, Journal of biomedical materials research.
[182] A. Sahni,et al. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. , 2000, Blood.
[183] C. Schmidt,et al. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. , 2000, Biomaterials.
[184] J. Isner,et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[185] G. Stevens,et al. New Murine Model of Spontaneous Autologous Tissue Engineering, Combining an Arteriovenous Pedicle with Matrix Materials , 2004, Plastic and reconstructive surgery.